Northside Capital Management, LLC Biogen Inc. Transaction History

Northside Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$236.26 - $355.63 $188,299 - $283,437	-797 Closed	0 $0
Q4 2019 Jan 09, 2020	BUY	$220.06 - $304.07 $175,387 - $242,343	797 New	797 $236,000
Q2 2019 Jul 16, 2019	SELL	$219.29 - $241.72 $186,835 - $205,945	-852 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$281.15 - $329.69 $239,539 - $280,895	852	852 $267,000

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Northside Capital Management, LLC with notifications on news.